Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Onconetix, Inc. - Common Stock (NQ:ONCO)

0.0899 +0.0087 (+10.71%)
Streaming Delayed Price Updated: 3:48 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,863,243
Open 0.0860
Bid (Size) 0.0892 (6)
Ask (Size) 0.0900 (7)
Prev. Close 0.0812
Today's Range 0.0820 - 0.0990
52wk Range 0.0502 - 21.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stay updated with the stocks that are on the move in today's after-hours session.
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Performance

YTD
-86.2%
-86.2%
1 Month
+65.6%
+65.6%
3 Month
-82.0%
-82.0%
6 Month
-92.4%
-92.4%
1 Year
-98.6%
-98.6%

More News

Read More
Which stocks are moving on Wednesday?
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Via Chartmill
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
From Onconetix, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Which stocks are moving on Wednesday?
Via Chartmill
Why Onconetix (ONCO) Stock Is Exploding Higher
Via Benzinga
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
From Onconetix, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Top movers in Wednesday's pre-market session
Via Chartmill
Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort
From Onconetix, Inc.
Via GlobeNewswire
In today's session, these stocks are experiencing unusual volume.
Via Chartmill
Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress
From Onconetix, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
These stocks are making the most noise in today's session.
Via Chartmill
These stocks are moving in today's session
Via Chartmill
Traders are paying attention to the gapping stocks in Monday's session.
Via Chartmill
These stocks that are showing activity before the opening bell on Monday.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Topics Economy
Exposures Supply Chain
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Onconetix, Inc. - Common Stock publicly traded?
Yes, Onconetix, Inc. - Common Stock is publicly traded.
What exchange does Onconetix, Inc. - Common Stock trade on?
Onconetix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Onconetix, Inc. - Common Stock?
The ticker symbol for Onconetix, Inc. - Common Stock is ONCO on the Nasdaq Stock Market
What is the current price of Onconetix, Inc. - Common Stock?
The current price of Onconetix, Inc. - Common Stock is 0.0899
When was Onconetix, Inc. - Common Stock last traded?
The last trade of Onconetix, Inc. - Common Stock was at 05/20/25 03:48 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.